ProPhase Labs, Inc. Inventory Adjustments
ProPhase Labs, Inc. (PRPH) had Inventory Adjustments of $87.00 thousand as of 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Notes › Inventory
us-gaap:InventoryAdjustments · last filed 2021-11-12
- 2021-09-30: Inventory Adjustments $87.00K.
- 2021-06-30: Inventory Adjustments $87.00K.
- 2021-03-31: Inventory Adjustments $89.00K.
- 2020-12-31: Inventory Adjustments $167.00K.
| Period end | Inventory Adjustments | Inventory Adjustments as first filed |
|---|---|---|
| 2021-09-30 | $87.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $87.00K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $89.00K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $167.00K 10-Q · filed 2021-11-12 | |
| 2020-09-30 | $17.00K 10-Q · filed 2020-11-19 | |
| 2020-06-30 | $32.00K 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $12.00K 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $360.82K 10-K · filed 2021-03-31 | $168.00K 10-K · filed 2020-03-26 |
| 2019-09-30 | $344.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-11 | $382.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $10.00K 10-Q · filed 2020-05-12 | $372.00K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $103.00K 10-K · filed 2020-03-26 | $377.00K 10-K · filed 2019-03-26 |
| 2018-09-30 | $427.00K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $495.00K 10-Q · filed 2018-08-20 | |
| 2018-03-31 | $558.00K 10-Q/A · filed 2018-08-20 | |
| 2017-12-31 | $1.10M 10-K · filed 2019-03-26 | |
| 2017-09-30 | $1.50M 10-Q/A · filed 2018-08-20 | |
| 2017-06-30 | $1.70M 10-Q/A · filed 2018-08-20 | |
| 2017-03-31 | $1.40M 10-Q/A · filed 2018-08-20 | |
| 2016-12-31 | $1.60M 10-Q/A · filed 2018-08-20 | |
| 2016-09-30 | $628.00K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $531.00K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $476.00K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $501.00K 10-K · filed 2017-02-24 | |
| 2015-09-30 | $431.00K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $389.00K 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $505.00K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $797.00K 10-K · filed 2016-03-29 | |
| 2013-12-31 | $635.00K 10-K · filed 2015-03-27 | |
| 2012-12-31 | $890.00K 10-K · filed 2014-03-27 | |
| 2011-12-31 | $991.00K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |